vs

Side-by-side financial comparison of ESCO TECHNOLOGIES INC (ESE) and MERIT MEDICAL SYSTEMS INC (MMSI). Click either name above to swap in a different company.

MERIT MEDICAL SYSTEMS INC is the larger business by last-quarter revenue ($381.9M vs $289.7M, roughly 1.3× ESCO TECHNOLOGIES INC). MERIT MEDICAL SYSTEMS INC runs the higher net margin — 10.7% vs 9.9%, a 0.8% gap on every dollar of revenue. On growth, ESCO TECHNOLOGIES INC posted the faster year-over-year revenue change (17.3% vs 7.5%). ESCO TECHNOLOGIES INC produced more free cash flow last quarter ($63.0M vs $24.7M). Over the past eight quarters, ESCO TECHNOLOGIES INC's revenue compounded faster (7.8% CAGR vs 6.3%).

Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.

Merit Medical Systems Inc. is a global medical device firm that designs, manufactures, and markets a broad portfolio of interventional and diagnostic products used across cardiology, radiology, oncology, endoscopy, and critical care segments. It primarily serves hospitals, clinics, and healthcare providers worldwide, focusing on minimally invasive solutions that enhance patient outcomes and streamline clinical workflows.

ESE vs MMSI — Head-to-Head

Bigger by revenue
MMSI
MMSI
1.3× larger
MMSI
$381.9M
$289.7M
ESE
Growing faster (revenue YoY)
ESE
ESE
+9.8% gap
ESE
17.3%
7.5%
MMSI
Higher net margin
MMSI
MMSI
0.8% more per $
MMSI
10.7%
9.9%
ESE
More free cash flow
ESE
ESE
$38.3M more FCF
ESE
$63.0M
$24.7M
MMSI
Faster 2-yr revenue CAGR
ESE
ESE
Annualised
ESE
7.8%
6.3%
MMSI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ESE
ESE
MMSI
MMSI
Revenue
$289.7M
$381.9M
Net Profit
$28.7M
$41.0M
Gross Margin
41.4%
48.4%
Operating Margin
13.2%
11.6%
Net Margin
9.9%
10.7%
Revenue YoY
17.3%
7.5%
Net Profit YoY
22.2%
36.0%
EPS (diluted)
$1.11
$0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESE
ESE
MMSI
MMSI
Q1 26
$381.9M
Q4 25
$289.7M
$393.9M
Q3 25
$286.5M
$384.2M
Q2 25
$296.3M
$382.5M
Q1 25
$265.5M
$355.4M
Q4 24
$247.0M
$355.2M
Q3 24
$298.5M
$339.8M
Q2 24
$260.8M
$338.0M
Net Profit
ESE
ESE
MMSI
MMSI
Q1 26
$41.0M
Q4 25
$28.7M
$38.0M
Q3 25
$218.7M
$27.8M
Q2 25
$26.1M
$32.6M
Q1 25
$31.0M
$30.1M
Q4 24
$23.5M
$27.9M
Q3 24
$34.3M
$28.4M
Q2 24
$29.2M
$35.7M
Gross Margin
ESE
ESE
MMSI
MMSI
Q1 26
48.4%
Q4 25
41.4%
49.6%
Q3 25
45.9%
48.5%
Q2 25
41.2%
48.2%
Q1 25
41.1%
48.4%
Q4 24
39.8%
48.7%
Q3 24
40.1%
46.4%
Q2 24
39.6%
47.7%
Operating Margin
ESE
ESE
MMSI
MMSI
Q1 26
11.6%
Q4 25
13.2%
13.8%
Q3 25
17.2%
11.1%
Q2 25
11.2%
12.3%
Q1 25
15.3%
11.5%
Q4 24
11.4%
10.3%
Q3 24
14.8%
11.0%
Q2 24
14.3%
13.6%
Net Margin
ESE
ESE
MMSI
MMSI
Q1 26
10.7%
Q4 25
9.9%
9.6%
Q3 25
76.3%
7.2%
Q2 25
8.8%
8.5%
Q1 25
11.7%
8.5%
Q4 24
9.5%
7.9%
Q3 24
11.5%
8.4%
Q2 24
11.2%
10.6%
EPS (diluted)
ESE
ESE
MMSI
MMSI
Q1 26
$0.68
Q4 25
$1.11
$0.64
Q3 25
$8.43
$0.46
Q2 25
$1.01
$0.54
Q1 25
$1.20
$0.49
Q4 24
$0.91
$0.46
Q3 24
$1.32
$0.48
Q2 24
$1.13
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESE
ESE
MMSI
MMSI
Cash + ST InvestmentsLiquidity on hand
$103.8M
$488.1M
Total DebtLower is stronger
$145.5M
$735.2M
Stockholders' EquityBook value
$1.6B
$1.6B
Total Assets
$2.4B
$2.7B
Debt / EquityLower = less leverage
0.09×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESE
ESE
MMSI
MMSI
Q1 26
$488.1M
Q4 25
$103.8M
$446.4M
Q3 25
$101.3M
$392.5M
Q2 25
$78.7M
$341.8M
Q1 25
$57.4M
$395.5M
Q4 24
$71.3M
$376.7M
Q3 24
$66.0M
$523.1M
Q2 24
$63.0M
$636.7M
Total Debt
ESE
ESE
MMSI
MMSI
Q1 26
$735.2M
Q4 25
$145.5M
$734.0M
Q3 25
$186.0M
$732.9M
Q2 25
$525.0M
$731.8M
Q1 25
$88.0M
$730.7M
Q4 24
$112.0M
$729.6M
Q3 24
$122.0M
$750.5M
Q2 24
$173.0M
$801.3M
Stockholders' Equity
ESE
ESE
MMSI
MMSI
Q1 26
$1.6B
Q4 25
$1.6B
$1.6B
Q3 25
$1.5B
$1.5B
Q2 25
$1.3B
$1.5B
Q1 25
$1.3B
$1.4B
Q4 24
$1.2B
$1.4B
Q3 24
$1.2B
$1.3B
Q2 24
$1.2B
$1.3B
Total Assets
ESE
ESE
MMSI
MMSI
Q1 26
$2.7B
Q4 25
$2.4B
$2.7B
Q3 25
$2.4B
$2.6B
Q2 25
$2.5B
$2.6B
Q1 25
$1.8B
$2.5B
Q4 24
$1.8B
$2.4B
Q3 24
$1.8B
$2.4B
Q2 24
$1.8B
$2.4B
Debt / Equity
ESE
ESE
MMSI
MMSI
Q1 26
0.45×
Q4 25
0.09×
0.46×
Q3 25
0.12×
0.48×
Q2 25
0.40×
0.49×
Q1 25
0.07×
0.51×
Q4 24
0.09×
0.53×
Q3 24
0.10×
0.57×
Q2 24
0.14×
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESE
ESE
MMSI
MMSI
Operating Cash FlowLast quarter
$68.9M
Free Cash FlowOCF − Capex
$63.0M
$24.7M
FCF MarginFCF / Revenue
21.7%
6.5%
Capex IntensityCapex / Revenue
2.0%
4.2%
Cash ConversionOCF / Net Profit
2.40×
TTM Free Cash FlowTrailing 4 quarters
$239.6M
$220.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESE
ESE
MMSI
MMSI
Q1 26
Q4 25
$68.9M
$98.5M
Q3 25
$109.9M
$75.0M
Q2 25
$73.7M
$83.3M
Q1 25
$24.1M
$40.6M
Q4 24
$34.2M
$68.7M
Q3 24
$72.1M
$47.3M
Q2 24
$36.2M
$68.5M
Free Cash Flow
ESE
ESE
MMSI
MMSI
Q1 26
$24.7M
Q4 25
$63.0M
$74.0M
Q3 25
$97.8M
$52.5M
Q2 25
$64.9M
$69.6M
Q1 25
$14.0M
$19.5M
Q4 24
$29.0M
$65.3M
Q3 24
$60.9M
$38.0M
Q2 24
$27.6M
$57.9M
FCF Margin
ESE
ESE
MMSI
MMSI
Q1 26
6.5%
Q4 25
21.7%
18.8%
Q3 25
34.1%
13.7%
Q2 25
21.9%
18.2%
Q1 25
5.3%
5.5%
Q4 24
11.7%
18.4%
Q3 24
20.4%
11.2%
Q2 24
10.6%
17.1%
Capex Intensity
ESE
ESE
MMSI
MMSI
Q1 26
4.2%
Q4 25
2.0%
6.2%
Q3 25
4.2%
5.8%
Q2 25
3.0%
3.6%
Q1 25
3.8%
5.9%
Q4 24
2.1%
1.0%
Q3 24
3.8%
2.8%
Q2 24
3.3%
3.1%
Cash Conversion
ESE
ESE
MMSI
MMSI
Q1 26
Q4 25
2.40×
2.59×
Q3 25
0.50×
2.70×
Q2 25
2.83×
2.56×
Q1 25
0.78×
1.35×
Q4 24
1.46×
2.46×
Q3 24
2.10×
1.66×
Q2 24
1.24×
1.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESE
ESE

US Government$98.0M34%
Utility Solutions Group$87.5M30%
RF Shielding And Test$58.3M20%
Commercial$45.8M16%
Related Party$1.3M0%

MMSI
MMSI

Segment breakdown not available.

Related Comparisons